Anticholinergic drugs and dementia: time for transparency in the face of uncertainty
- PMID: 34494256
- PMCID: PMC9629772
- DOI: 10.1002/14651858.ED000154
Anticholinergic drugs and dementia: time for transparency in the face of uncertainty
Keywords: Ageing; Mental health; Neurology.
Comment on
-
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.Cochrane Database Syst Rev. 2021 May 5;5(5):CD013540. doi: 10.1002/14651858.CD013540.pub2. Cochrane Database Syst Rev. 2021. PMID: 34097766 Free PMC article.
References
-
- Durán CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology 2013;69:1485–96. https://doi.org/10.1007/s00228-013-1499-3 - PubMed
-
- Naples JG, Marcum ZA, Perera S, Gray SL, Newman AB, Simonsick EM, et al. Concordance between anticholinergic burden scales. Journal of the American Geriatric Society 2015;63:2120–4. https://doi.org/10.1111/jgs.13647 - PMC - PubMed
-
- Taylor‐Rowan M, Edwards S, Noel‐Storr AH, McCleery J, Myint PK, Soiza R, et al. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome. Cochrane Database Systematic Reviews 2021;(5):CD013540. https://doi.org/10.1002/14651858.CD013540.pub2 - PMC - PubMed
-
- Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics 2001;26:331–42. https://doi.org/10.1046/j.1365-2710.2001.00363.x - PubMed
-
- Chen R, Hu Z, Wei L, Qin X, Copeland JR. Is the relationship between syndromes of depression and dementia temporal? The MRC‐ALPHA and Hefei‐China studies. Psychological Medicine 2009;39:425–30. https://doi.org/10.1017/S0033291708003735 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical